The current 200mg and 600mg packages on the Swiss market do not contain the most recently approved Patient Information Leaflet.
The new adverse event Acute Generalized exanthematous pustulosis (AGEP) is missing under section “Possible side effects’’ of the leaflet.
For more information, please refer to the company's information letter.